Reduction of bacterial load with the addition of ultraviolet-C disinfection inside the hyperbaric chamber.

Introduction: Healthcare acquired infections (HAIs) are associated with increased mortality, morbidity and prolonged hospital stays. Microbiological contamination of the hospital environment directly contributes to HAIs. Optimising environmental cleaning reduces transmission of HAIs.

Hyperbaric oxygen therapy for acute coronary syndrome.

Background: Acute coronary syndrome (ACS), includes acute myocardial infarction and unstable angina, is common and may prove fatal. Hyperbaric oxygen therapy (HBOT) will improve oxygen supply to the threatened heart and may reduce the volume of heart muscle that perishes. The addition of HBOT to standard treatment may reduce death rate and other major adverse outcomes.

Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus.

Background: This is an update of a Cochrane Review first published in The Cochrane Library in Issue 1, 2005 and previously updated in 2007 and 2009.Idiopathic sudden sensorineural hearing loss (ISSHL) is common and has a significant effect on quality of life. Hyperbaric oxygen therapy (HBOT) may improve oxygen supply to the inner ear and result in an improvement in hearing.

Recompression and adjunctive therapy for decompression illness.

Background: Decompression illness (DCI) is due to bubble formation in the blood or tissues following the breathing of compressed gas. Clinically, DCI may range from a trivial illness to loss of consciousness, death or paralysis. Recompression is the universally accepted standard treatment of DCI.

Hyperbaric oxygen therapy for acute coronary syndrome.

Background: Acute coronary syndrome (ACS), includes acute myocardial infarction and unstable angina, is common and may prove fatal. Hyperbaric oxygen therapy (HBOT) will improve oxygen supply to the threatened heart and may reduce the volume of heart muscle that perishes. The addition of HBOT to standard treatment may reduce death rate and other major adverse outcomes.

Recompression and adjunctive therapy for decompression illness: a systematic review of randomized controlled trials.

Introduction: Decompression illness (DCI) is caused by bubble formation in the blood or tissues after a reduction in ambient pressure. Clinically, DCI may range from a trivial illness to paralysis, loss of consciousness, cardiovascular collapse, and death. Recompression is the universally accepted standard for the treatment of DCI.

Recompression and adjunctive therapy for decompression illness: a systematic review of randomised controlled trials.

Introduction: Decompression illness (DCI) results from bubble formation in the blood or tissues following the breathing of compressed gas. Recompression is the universally accepted standard for the treatment of DCI, but a number of strategies have been suggested in order to improve the outcome.

Methods: We performed a systematic search of the literature in December 2007 for randomised controlled trials of DCI therapy, and made an analysis of pre-determined clinical outcomes.